Sanjivani Paranteral Ltd. (SANJIVIN) Share Price Rises 9.14% Today
- August 6, 2026
- Posted by: Harsh Piplani
- Category: News
Sanjivani Paranteral Ltd. Share Price rises 9.14% today, reaching Rs 209 with a market cap of Rs 196.06 crore.
Sanjivani Paranteral Ltd. Share Price today saw a significant rise of 9.14%, closing at Rs 209. This notable increase in share price comes with a market capitalisation of Rs 196.06 crore, placing it in the Micro Cap category. The stock opened at Rs 195 and reached a high of Rs 209, with a low of Rs 180.5 during the trading session. The total volume traded on the BSE was 16,896 shares, resulting in a turnover of Rs 0.35 crore. This price action places Sanjivani Paranteral Ltd.
The price rise of Sanjivani Paranteral Ltd. is noteworthy as it reflects investor interest and market dynamics. While the data confirms the price event, it does not establish a company-specific catalyst for today’s rally. Investors and analysts will be keen to explore the technical and fundamental aspects to understand the underlying factors contributing to this movement.
Sanjivani Paranteral Ltd. (SANJIVIN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 209 |
| Previous Close | Rs 191.5 |
| Today's Change | +Rs 17.5 (+9.14%) |
| Day Open | Rs 195 |
| Day High | Rs 209 |
| Day Low | Rs 180.5 |
| Current Volume (BSE) | 16,896 |
| BSE Traded Volume | 16,896 |
| Combined NSE + BSE Volume | 16,896 |
| Turnover | Rs 0.35 crore |
| Market Capitalisation | Rs 196.06 crore |
| Market Cap Category | Micro Cap |
Sanjivani Paranteral Ltd. (SANJIVIN) traded at Rs 209. versus the previous close of Rs 191.5, a rise of 9.14%. The stock opened at Rs 195, reached Rs 209, touched Rs 180.5. Reported volume was 16,896.
Sanjivani Paranteral Ltd. (SANJIVIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 196.06 crore |
| P/E Ratio | 34.67x |
| P/B Ratio | 4.88x |
| ROE | 0% |
| ROCE | 266.43% |
| EPS | Rs 5.52 |
| Dividend Yield | 0% |
Sanjivani Paranteral Ltd. was valued at a P/E ratio of 34.67x, a P/B ratio of 4.88x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 0% and ROCE of 266.43%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 5.52, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sanjivani Paranteral Ltd. has a market capitalisation of Rs 196.06 crore and an enterprise value that reflects its position in the Micro Cap category. The company’s P/E ratio stands at 34.67, which is above the industry median of 26.22 but below the average of 81.19. The P/B ratio is 4.88, significantly higher than the industry median of 1.86, indicating a premium valuation.
The company’s ROE is 0, while the ROCE is an impressive 266.43, far exceeding the industry median of 12.98. The EPS is Rs 5.52, reflecting the earnings attributable to each share. The book value per share is not supplied, and the dividend yield is 0, indicating no historical payout relative to the current price.
The fundamental analysis highlights the company’s strong ROCE, which may attract investor interest despite the lack of dividend yield. The valuation multiples suggest that the stock is trading at a premium compared to its industry peers, which may be justified by its strong operational performance.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 34.67x |
| Benchmark Median P/E | 26.22x |
| Benchmark Average P/E | 81.19x |
| Benchmark P/E Range | 3.23x to 3,428.55x |
| Company P/B Ratio | 4.88x |
| Benchmark Median P/B | 1.86x |
| Company ROE | 0% |
| Benchmark Median ROE | 10.59% |
| Company ROCE | 266.43% |
| Benchmark Median ROCE | 12.98% |
| Company Market Capitalisation | Rs 196.06 crore |
| Benchmark Median Market Cap | Rs 145.72 crore |
Sanjivani Paranteral Ltd. (SANJIVIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 34.67x, which is above the benchmark median of 26.22x, a difference of +32.23%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanjivani Paranteral Ltd. (SANJIVIN) has a ROE of 0%, which is below the benchmark median of 10.59%, a difference of -100%. Sanjivani Paranteral Ltd. (SANJIVIN) has a ROCE of 266.43%, which is above the benchmark median of 12.98%, a difference of +1,952.62%.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
Sanjivani Paranteral Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry. The sector snapshot reveals that the company’s P/E ratio of 34.67 is above the industry median of 26.22 but below the average of 81.19. The P/B ratio of 4.88 is significantly higher than the industry median of 1.86, indicating a premium valuation.
The company’s ROE is 0, while the ROCE is an impressive 266.43, far exceeding the industry median of 12.98. The market capitalisation of Rs 196.06 crore places it below the industry median of Rs 145.72 crore, highlighting its position as a Micro Cap stock.
The sector analysis provides context for the company’s valuation and performance, with its strong ROCE standing out as a key differentiator. The company’s premium valuation may be justified by its strong operational performance, attracting investor interest in the competitive Pharmaceuticals & Drugs industry.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,943.6 | 31.4 | 0.46 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,812.49 | 0 | 2.39 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,684.11 | 39.39 | 8.02 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,621.81 | 63.25 | 10.01 | 18.65 | 22.17 |
| Panacea Biotec Ltd. | PANACEABIO | 2,566.71 | 0 | 3.08 | 0 | 5.36 |
Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 34.67x compared with the displayed peer median of 31.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 266.43% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Sanjivani Paranteral Ltd. (SANJIVIN) has a market capitalisation of Rs 196.06 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
In comparison to its peers, Sanjivani Paranteral Ltd. has a P/E ratio of 34.67, which is higher than Dishman Carbogen Amcis Ltd. (31.4) but lower than Kwality Pharmaceuticals Ltd. (39.39) and Beta Drugs Ltd. (63.25). The company’s P/B ratio of 4.88 is higher than Hikal Ltd. (2.39) and Solara Active Pharma Sciences Ltd. (1.95), indicating a premium valuation.
The company’s ROE is 0, while its ROCE of 266.43 is significantly higher than its peers, such as Hikal Ltd. (16.15) and Kwality Pharmaceuticals Ltd. (26.35). The market capitalisation of Rs 196.06 crore places it below its peers, highlighting its position as a Micro Cap stock.
The peer comparison underscores the company’s strong ROCE and premium valuation, which may attract investor interest despite its smaller market capitalisation.
Why Investors Are Watching Sanjivani Paranteral Ltd.
Investors are closely monitoring Sanjivani Paranteral Ltd. due to its recent price rise and strong operational performance. The company’s premium valuation and impressive ROCE make it a standout in the Pharmaceuticals & Drugs industry.
- Price Action: 9.14% rise today, closing at Rs 209.
- Technical Position: RSI of 62.91 indicates strong momentum.
- Fundamental Context: Premium valuation with a P/E of 34.67 and ROCE of 266.43.
- Sector Positioning: Operates in the competitive Pharmaceuticals & Drugs industry.
As the stock continues to attract interest, investors will be keen to monitor its price action, technical indicators, and fundamental performance to gauge future movements.
About Sanjivani Paranteral Ltd.
Sanjivani Paranteral Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The company focuses on the production and distribution of pharmaceutical products, catering to a diverse range of healthcare needs. With a market capitalisation of Rs 196.06 crore, it is classified as a Micro Cap stock.
The company’s operations are centered around the development and manufacturing of parenteral drugs, which are administered through injections. This niche focus allows Sanjivani Paranteral Ltd. to cater to specific medical requirements, positioning it as a key player in the Pharmaceuticals & Drugs industry.
Track Sanjivani Paranteral Ltd. Share Price on Univest
Use Sanjivani Paranteral Ltd. (SANJIVIN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Investors can track Sanjivani Paranteral Ltd. Share Price on Univest to stay updated on live share prices, technical indicators, fundamental ratios, and shareholding patterns. Univest provides comprehensive market insights, including 52-week levels and industry trends, enabling investors to make informed decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Sanjivani Paranteral Ltd.?
Ans. The current share price of Sanjivani Paranteral Ltd. is Rs 209, reflecting a 9.14% increase from the previous close of Rs 191.5. The stock moved 9.14% during the session. The intraday range extended from Rs 180.5 to Rs 209.
How much did Sanjivani Paranteral Ltd. share price rise today?
Ans. Sanjivani Paranteral Ltd. share price rose by 9.14% today, closing at Rs 209, up from the previous close of Rs 191.5. The stock moved 9.14% during the session. The intraday range extended from Rs 180.5 to Rs 209.
What is the market capitalisation of Sanjivani Paranteral Ltd.?
Ans. The market capitalisation of Sanjivani Paranteral Ltd. is Rs 196.06 crore, classifying it as a Micro Cap stock in the Healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 34.67x.
What is the P/E ratio of Sanjivani Paranteral Ltd.?
Ans. The P/E ratio of Sanjivani Paranteral Ltd. is 34.67, which is above the industry median of 26.22 but below the average of 81.19. The company trades at a P/E ratio of 34.67x.
What is the ROCE of Sanjivani Paranteral Ltd.?
Ans. Sanjivani Paranteral Ltd. has a ROCE of 266.43, significantly higher than the industry median of 12.98, indicating strong operational performance. ROE stands at 0%. ROCE stands at 266.43%. The relevant peer median ROE is 10.59%.
How does Sanjivani Paranteral Ltd. compare to its peers?
Ans. Sanjivani Paranteral Ltd. has a higher P/E ratio than Dishman Carbogen Amcis Ltd. but lower than Kwality Pharmaceuticals Ltd., with a strong ROCE compared to its peers. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.
What industry does Sanjivani Paranteral Ltd. operate in?
Ans. Sanjivani Paranteral Ltd. operates in the Pharmaceuticals & Drugs industry, focusing on the production and distribution of parenteral drugs. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.
Where can I track Sanjivani Paranteral Ltd. share price?
Ans. You can track Sanjivani Paranteral Ltd. share price on Univest, which provides live updates, technical indicators, and comprehensive market insights. The stock moved 9.14% during the session. The intraday range extended from Rs 180.5 to Rs 209.
